http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2007143325-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D267-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-553
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
filingDate 2006-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2009-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2007143325-A
titleOfInvention MEDICINE FOR Xanthoma
abstract 1. A means of preventing and / or treating xanthomatosis, or physical dysfunction, or cosmetic disorder that results from the formation of xanthomas, including a compound having an inhibitory effect on squalene synthase, its prodrug, or its salt. ! 2. The tool according to claim 1, which is a prophylactic and / or therapeutic agent for xanthomatosis. ! 3. The tool according to claim 1, where the compound having an inhibitory effect on squalene synthase is a compound of the formula! ! where R1 represents hydrogen or an optionally substituted hydrocarbon group; R 2 and R 3 are the same or different and represent a hydrogen atom, an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group; X 'represents an optionally esterified carboxyl group, an optionally substituted carbamoyl group, an optionally substituted hydroxyl group, an optionally substituted amino group or a group consisting of an optionally substituted heterocyclic residue containing a hydrogen atom that can be deprotonated; ring A is an optionally substituted benzene ring or an optionally substituted heterocycle; ring J ′ is a 7-8 membered heterocycle containing three or less heteroatoms as ring-forming atoms, and ring J ′ may contain, in addition to R1, R2, R3 and X ′, an additional substituent. ! 4. The tool according to claim 1, where the compound having an inhibitory effect on squalene synthase is a compound of the formula! ! where R1 is optionally substituted
priorityDate 2005-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ7S4Z6
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9Y753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426515194
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424749766
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420472916
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11975273
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7991
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP53800
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11365164
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414922772
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ752X9
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO74165
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421521936
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP53798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413807576
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ54DR1
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393346
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ92459
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281767
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP29704
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID477362
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396411
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11353769
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0SJQ5
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID740684
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP36596
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID29580
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID14137
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474451
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID571911
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11489427
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9HGZ6
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394671
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1032
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5R6U3
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP37268
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID422038
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2222
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ32KR6
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11307796
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11978598
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP78589
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ02769
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413687353

Total number of triples: 69.